253 related articles for article (PubMed ID: 9088861)
1. Relationship between low-density lipoprotein size and apolipoprotein A-I-containing particles: the ECTIM study.
Luc G; Bard JM; Poulain P; Arveiler D; Evans AE; Cambien F; Fruchart JC; Ducimetière P
Eur J Clin Invest; 1997 Mar; 27(3):242-7. PubMed ID: 9088861
[TBL] [Abstract][Full Text] [Related]
2. ApoA-IHelsinki (Lys107-->0) associated with reduced HDL cholesterol and LpA-I:A-II deficiency.
Tilly-Kiesi M; Zhang Q; Ehnholm S; Kahri J; Lahdenperä S; Ehnholm C; Taskinen MR
Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1294-306. PubMed ID: 7670941
[TBL] [Abstract][Full Text] [Related]
3. Concentrations of apolipoprotein A-I-containing particles in patients with hypoalphalipoproteinemia.
Montali A; Vega GL; Grundy SM
Arterioscler Thromb; 1994 Apr; 14(4):511-7. PubMed ID: 8148349
[TBL] [Abstract][Full Text] [Related]
4. HDL subpopulations containing apoA-I without apoA-II (LpA-I) in patients with angiographically proven coronary artery disease.
Kuchta A; Strzelecki A; Ćwiklińska A; Gruchała M; Zdrojewski Z; Kortas-Stempak B; Wieczorek E; Gliwińska A; Dąbkowski K; Jankowski M
J Cardiol; 2017 Mar; 69(3):523-528. PubMed ID: 27169356
[TBL] [Abstract][Full Text] [Related]
5. Formation of apolipoprotein-specific high-density lipoprotein particles from lipid-free apolipoproteins A-I and A-II.
Clay MA; Cehic DA; Pyle DH; Rye KA; Barter PJ
Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):445-51. PubMed ID: 9895287
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity.
Ooi EM; Watts GF; Sprecher DL; Chan DC; Barrett PH
J Clin Endocrinol Metab; 2011 Oct; 96(10):E1568-76. PubMed ID: 21816786
[TBL] [Abstract][Full Text] [Related]
7. High-density lipoprotein (HDL) transport in the metabolic syndrome: application of a new model for HDL particle kinetics.
Ji J; Watts GF; Johnson AG; Chan DC; Ooi EM; Rye KA; Serone AP; Barrett PH
J Clin Endocrinol Metab; 2006 Mar; 91(3):973-9. PubMed ID: 16368749
[TBL] [Abstract][Full Text] [Related]
8. Distribution of ApoA-I-containing HDL subpopulations in patients with coronary heart disease.
Asztalos BF; Roheim PS; Milani RL; Lefevre M; McNamara JR; Horvath KV; Schaefer EJ
Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2670-6. PubMed ID: 11116070
[TBL] [Abstract][Full Text] [Related]
9. Speciated human high-density lipoprotein protein proximity profiles.
Gauthamadasa K; Rosales C; Pownall HJ; Macha S; Jerome WG; Huang R; Silva RA
Biochemistry; 2010 Dec; 49(50):10656-65. PubMed ID: 21073165
[TBL] [Abstract][Full Text] [Related]
10. Volumetric determination of apolipoprotein stoichiometry of circulating HDL subspecies.
Segrest JP; Cheung MC; Jones MK
J Lipid Res; 2013 Oct; 54(10):2733-44. PubMed ID: 23883582
[TBL] [Abstract][Full Text] [Related]
11. Distribution of subclasses of HDL containing apoA-I without apoA-II (LpA-I) in normolipidemic men and women.
Duverger N; Rader D; Brewer HB
Arterioscler Thromb; 1994 Oct; 14(10):1594-9. PubMed ID: 7918309
[TBL] [Abstract][Full Text] [Related]
12. HDLs containing apolipoproteins A-I and A-II (LpA-I:A-II) as markers of coronary artery disease in men with non-insulin-dependent diabetes mellitus.
Syvänne M; Kahri J; Virtanen KS; Taskinen MR
Circulation; 1995 Aug; 92(3):364-70. PubMed ID: 7634450
[TBL] [Abstract][Full Text] [Related]
13. High-density lipoprotein subpopulation profiles in lipoprotein lipase and hepatic lipase deficiency.
Tani M; Horvath KV; Lamarche B; Couture P; Burnett JR; Schaefer EJ; Asztalos BF
Atherosclerosis; 2016 Oct; 253():7-14. PubMed ID: 27573733
[TBL] [Abstract][Full Text] [Related]
14. High density lipoprotein particle size restriction in apolipoprotein A-I(Milano) transgenic mice.
Bielicki JK; Forte TM; McCall MR; Stoltzfus LJ; Chiesa G; Sirtori CR; Franceschini G; Rubin EM
J Lipid Res; 1997 Nov; 38(11):2314-21. PubMed ID: 9392429
[TBL] [Abstract][Full Text] [Related]
15. The role of lipoprotein A-I and lipoprotein A-I/A-II in predicting coronary artery disease.
O'Brien T; Nguyen TT; Hallaway BJ; Hodge D; Bailey K; Holmes D; Kottke BA
Arterioscler Thromb Vasc Biol; 1995 Feb; 15(2):228-31. PubMed ID: 7749830
[TBL] [Abstract][Full Text] [Related]
16. Remodeling of HDL containing apoA-I but not apoA-II (LpA-I) by lipoprotein-deficient plasma and hepatic lipase: its effect on the structure and cellular cholesterol-reducing capacity of LpA-I.
Ohta T; Ikeda Y; Hattori S; Matsuda I
Biochim Biophys Acta; 1996 Sep; 1303(2):137-44. PubMed ID: 8856043
[TBL] [Abstract][Full Text] [Related]
17. Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease.
Rader DJ; Ikewaki K; Duverger N; Schmidt H; Pritchard H; Frohlich J; Clerc M; Dumon MF; Fairwell T; Zech L
J Clin Invest; 1994 Jan; 93(1):321-30. PubMed ID: 8282802
[TBL] [Abstract][Full Text] [Related]
18. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein A-II production rate is a major factor regulating the distribution of apolipoprotein A-I among HDL subclasses LpA-I and LpA-I:A-II in normolipidemic humans.
Ikewaki K; Zech LA; Kindt M; Brewer HB; Rader DJ
Arterioscler Thromb Vasc Biol; 1995 Mar; 15(3):306-12. PubMed ID: 7749839
[TBL] [Abstract][Full Text] [Related]
20. Contrasting in vivo effects of murine and human apolipoprotein A-II. Role of monomer versus dimer.
Gong EL; Stoltfus LJ; Brion CM; Murugesh D; Rubin EM
J Biol Chem; 1996 Mar; 271(11):5984-7. PubMed ID: 8626380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
